AIMON SANGWANPANICH: Open Payments
NPI 1578164166 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 8 payments from 4 companies in 2025. Trend: 2023 $369 · 2024 $1,050 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 4 | $387 |
| Novo Nordisk Inc | 1 | $121 |
| AstraZeneca Pharmaceuticals LP | 1 | $109 |
| Ardelyx, Inc. | 2 | $62 |
Products named: Vafseo, Ozempic, LOKELMA, IBSRELA.
Industry payments across CA — which companies pay providers there.
